Oruka Therapeutics, Inc. Operating Loss Carryforwards
Oruka Therapeutics, Inc. (ORKA) had Operating Loss Carryforwards of $208.10 million as of 2023-12-31, per its 10-K filed 2024-02-01.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2024-02-01
- 2023-12-31: Operating Loss Carryforwards $208.10M.
- 2022-12-31: Operating Loss Carryforwards $203.30M.
- 2021-12-31: Operating Loss Carryforwards $197.30M.
- 2020-12-31: Operating Loss Carryforwards $179.50M.
| Period end | Operating Loss Carryforwards | Operating Loss Carryforwards as first filed |
|---|---|---|
| 2023-12-31 | $208.10M 10-K · filed 2024-02-01 | |
| 2022-12-31 | $203.30M 10-K · filed 2023-02-24 | |
| 2021-12-31 | $197.30M 10-K · filed 2022-03-14 | |
| 2020-12-31 | $179.50M 10-K · filed 2021-03-18 | |
| 2018-12-31 | $170.30M 10-K · filed 2020-02-18 | $165.20M 10-K · filed 2019-02-27 |
| 2017-12-31 | $156.40M 10-K · filed 2018-03-22 | |
| 2016-12-31 | $139.70M 10-K · filed 2017-03-21 | |
| 2015-12-31 | $124.30M 10-K · filed 2016-03-17 | |
| 2014-12-31 | $113.70M 10-K · filed 2015-03-19 | |
| 2013-12-31 | $104.70M 10-K · filed 2014-03-20 | |
| 2012-12-31 | $98.10M 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |